Is This Why Nkarta (NKTX) Stock Rises Premarket?
In premarket trading, shares of biopharmaceutical company developing engineered NK cell therapies to treat cancer Nkarta Inc. (NASDAQ: NKTX) rose 14.62% to $29.71 at last check. Last session, Nkarta closed at $25.92, decreasing by -5.30% or $1.45. In the course of the day, price of NKTX stock fluctuated in the range from $24.50 to $27.23. […]
